<DOC>
	<DOCNO>NCT00636935</DOCNO>
	<brief_summary>To explore effect corticosteroid therapy pulmonary fibrosis potentially pneumothorax patient mild PCP ( pO2 &gt; 70mmHg ) combine standard care treatment antibiotic therapy .</brief_summary>
	<brief_title>Corticosteroids Therapy Pneumocystis Jirovecii Pneumonia ( PCP )</brief_title>
	<detailed_description>Although development highly active anti-retroviral therapy substantially reduce incidence Pneumocystis jirovecii pneumonia ( PCP ) among HIV-infected individual , PCP remain one common present opportunistic infection among population . The use adjunctive corticosteroid treatment patient moderate severe PCP result significant improvement development respiratory failure mortality . Past study demonstrate clinical benefit patient mild disease ( pO2 &gt; 75 torr room air ) . This may due fact patient mild disease develop either respiratory failure die course acute illness statistical difference could demonstrate . However , consider parameter mortality , evidence suggest patient high pO2 concentration benefit adjunctive corticosteroid . PCP associate development pulmonary fibrosis significant consequence . Pathological study show development interstitial fibrosis late course acute illness . Studies document presence diffuse interstitial pneumonitis five month onset acute illness . Therefore , patient PCP infection , regardless pO2 level presentation may benefit corticosteroid therapy . The current standard care therapy patient PCP involve addition corticosteroid standard antibiotic patient pO2 &gt; 70 mmHG . This study propose conduct randomize , prospective , un-blinded clinical trial explore effect corticosteroid therapy pulmonary fibrosis patient mild PCP admit George Washington University Hospital .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Pneumocystis</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Dapsone</mesh_term>
	<mesh_term>Trimethoprim , Sulfamethoxazole Drug Combination</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Primaquine</mesh_term>
	<mesh_term>Trimethoprim</mesh_term>
	<mesh_term>Pentamidine</mesh_term>
	<mesh_term>Atovaquone</mesh_term>
	<criteria>HIV Infection , Hospital admission suspect PCP , Confirmatory test PCP ( bronchoscopy bronchoalveolar lavage ) , pO2 &gt; 70 mmHg pO2 &lt; 70 mmHg breathing room air , 18 year old Contraindications corticosteroid therapy , Unable unwilling perform PFTS return followup evaluation , Underlying lung disease emphysema , untreated active tuberculosis , Uncontrolled diabetes ( fast glucose &gt; 250 mg/dL , Uncontrolled hypertension ( 160/95 mmHg ) , Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Pneumocystis jirovecii Pneumonia</keyword>
	<keyword>Corticosteroid Therapy</keyword>
	<keyword>HIV</keyword>
	<keyword>Pneumonia</keyword>
	<keyword>Pulmonary Function Testing</keyword>
	<keyword>Antibiotics</keyword>
	<keyword>Prednisone</keyword>
	<keyword>Human Immunodeficiency Virus</keyword>
	<keyword>CD4</keyword>
	<keyword>CD8</keyword>
	<keyword>Viral Load</keyword>
	<keyword>Bactrim</keyword>
	<keyword>Pentamidine</keyword>
	<keyword>Atovaquone</keyword>
	<keyword>Primaquine/Clindamycin</keyword>
	<keyword>Trimethoprim/Dapsone</keyword>
</DOC>